Description: Human serum albumin (HSA) is one of the most important carriers for acidic drugs in human plasma and has been shown to bind a large number of different compounds in a reversible manner.

Description: Human serum albumin (HSA) is one of the most important carriers for acidic drugs in human plasma and has been shown to bind a large number of different compounds in a reversible manner.

Description: JBS True Blue

Description: 71431-30-6

Description: The PCSK9 (D374Y) [Biotinylated]-LDLR Binding Assay Kit is designed for screening and profiling purposes. The kit comes in a convenient 96-well format and contains enough biotin-labeled mutant protein PCSK9 (D374Y), purified LDLR ectodomain, and HRP-conjugated streptavidin for 100 reactions. Moreover, two pre-formulated assay buffers are supplied to validate PCSK9-LDLR binding in either neutral or acidic binding conditions.This assay takes advantage of the high sensitivity of detection of biotin-labeled PCSK9 (D374Y) by streptavidin-HRP. First, a 96-well plate is coated with LDLR ectodomain. PCSK9 (D374Y) is then incubated with LDLR. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which is measured using a chemiluminescence reader.Need us to run inhibitor screens or profile your compounds against PCSK9 (D374Y) -LDLR? Check out ourPCSK9 Screening Services.

Description: Cell Biolabs? HIF-1 Alpha DNA Binding Activity Assay Kit is an immunoassay developed for rapid detection of activated HIF-1 in any protein sample. Active HIF-1 complex is captured on a double stranded oligonucleotide containing an HRE that is attached to the well. HIF-1 Alpha is then detected with an anti-HIF-1 Alpha antibody followed by an HRP conjugated secondary antibody. Each kit provides sufficient reagents to perform up to a total of 96 assays, and can detect HIF-1 Alpha from human, mouse, or rat. The HIF-1 DNA Binding Activity Assay takes only 4.5 hours to complete compared to a standard 3 day electromobility shift (EMSA) method.

Description: The MLL4 (KMT2B) : WDR5 Binding Chemiluminescent Assay Kit is an ELISA-based assay designed to measure the binding between MLL4 (mixed lineage leukemia protein-4, also known as KMT2B) and WDR5 (WD40 repeat-containing protein 5) for screening and profiling applications. The MLL4 (KMT2B) : WDR5 Binding Chemiluminescent Assay comes with enough purified MLL4 (amino acids 2490-2715) and WDR5 proteins, primary and secondary antibody, assay buffer, and detection reagent for 100 enzyme reactions.Figure 1. MLL4 (KMT2B) : WDR5 Binding Chemiluminescent Assay Kit schematic.A 96-well plate is coated with MLL4 protein. After coating and blocking, WDR5 is added in an optimized assay buffer. Next, unbound WDR5 is washed away, and the plate is incubated with a primary antibody followed by a secondary HRP-conjugated antibody. Finally, ELISA ECL substrate is added to produce chemiluminescence that can be measured using a chemiluminescence reader. The chemiluminescence signal is proportional to the efficacy of WDR5 binding to MLL4 (KMT2B) .Need us to run inhibitor screens or profile your compounds against MLL4 (KMT2B) : WDR5 binding? Check out ourMethyltransferase Screening and Profiling.

Description: This product includes 150 µl of 10 x Buffer, 150 µl of 10 x ssDNA (a 45-mer single-strand DNA) and 100 µl of 4 x gel loading buffer.